Eli Lilly and Co's Options Frenzy: What You Need to Know

Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly and Co.

Looking at options history for Eli Lilly and Co LLY we detected 87 trades.

If we consider the specifics of each trade, it is accurate to state that 47% of the investors opened trades with bullish expectations and 52% with bearish.

From the overall spotted trades, 28 are puts, for a total amount of $1,641,414 and 59, calls, for a total amount of $4,535,080.

Projected Price Targets

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $1180.0 for Eli Lilly and Co, spanning the last three months.

Analyzing Volume & Open Interest

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Eli Lilly and Co's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly and Co's whale activity within a strike price range from $300.0 to $1180.0 in the last 30 days.

Eli Lilly and Co Call and Put Volume: 30-Day Overview

Options Call Chart

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
LLY PUT TRADE BEARISH 06/20/25 $69.95 $61.05 $69.9 $700.00 $209.7K 8 0
LLY PUT TRADE BULLISH 06/20/25 $68.5 $62.25 $63.75 $700.00 $191.2K 8 30
LLY PUT SWEEP BEARISH 04/19/24 $23.25 $22.65 $23.25 $770.00 $88.3K 1.0K 391
LLY CALL TRADE BULLISH 01/17/25 $41.0 $40.45 $41.0 $900.00 $82.0K 1.4K 206
LLY PUT TRADE NEUTRAL 04/19/24 $24.15 $22.55 $23.35 $770.00 $81.7K 1.0K 356

About Eli Lilly and Co

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Current Position of Eli Lilly and Co

  • With a trading volume of 2,149,032, the price of LLY is up by 0.15%, reaching $747.87.
  • Current RSI values indicate that the stock is may be approaching oversold.
  • Next earnings report is scheduled for 13 days from now.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Eli Lilly and Co, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date of Trade
▲▼
ticker
▲▼
Put/Call
▲▼
Strike Price
▲▼
DTE
▲▼
Sentiment
▲▼
Posted In: OptionsMarketsBZI-UOA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!